Skip to content

The effect of superficial cervical plexus block on postoperative pain after shoulder surgery.

The effect of superficial cervical plexus block on postoperative pain after shoulder surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111677
Enrollment
Unknown
Registered
2025-11-04
Start date
2025-11-05
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tear

Interventions

Sponsors

The First People's Hospital of Tianshui
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male and female patients classified as ASA I-II, aged over 18 years, scheduled to undergo arthroscopic rotator cuff repair for unilateral rotator cuff injury.

Exclusion criteria

Exclusion criteria: 1.Patients who declined to participate in the study. 2.Inability to cooperate or communicate in Chinese. 3.Patients participating in other clinical trials. 4.Patients with severe cardiac, vascular, cerebral, renal, or hepatic diseases. 5.Patients with severe psychiatric disorders or those taking any psychotropic medications. 6.Contraindications to non-steroidal anti-inflammatory drugs (NSAIDs). 7.Contraindications to regional anesthesia (e.g., cervical spine deformity, significant neurological impairment, coagulation disorders, local infection at the block site, systemic infection, and/or allergy to local anesthetics). 8.Acute or chronic pain due to causes other than the rotator cuff injury. 9.Current use of any analgesic medications.

Design outcomes

Primary

MeasureTime frame
Cumulative sufentanil consumption at 48 hours postoperatively between the two groups.;

Secondary

MeasureTime frame
Assessment of sensory block coverage for the surgical incision at 30 minutes post-block.;Heart rate;Systolic blood pressure;Diastolic blood pressure;SPO2;The rate of diaphragmatic paralysis, defined as a greater than 75% reduction in hemidiaphragmatic excursion compared to the preoperative baseline.;Pulmonary function (including FVC, FEV1, and PEF);Operation Duration;Intraoperative sufentanil consumption;Time to first onset of pain;Time to first PCA demand;Resting and activity-induced pain NRS scores, and pain locations (anterior, superior, and posterior shoulder).;The number of patients with resting and activity-induced pain NRS scores >3 within the first 48 hours postoperatively and in the time intervals of 0-6h, 6-12h, 12-24h, and 24-48h. ;Postoperative sufentanil consumption in the 0-6h, 6-12h, 12-24h, and 24-48h periods.;Simple Joint Motion Score for the wrist, elbow, and shoulder;Time to onset of shoulder motor recovery, defined as the interval from surgery completion to active shoulder abduction in the supine position.;Time to onset of elbow motor recovery, defined as the interval from surgery completion to active elbow flexion.;Time to onset of wrist motor recovery, defined as the interval from surgery completion to active wrist flexion.;Complications associated with sufentanil (including postoperative nausea and vomiting (PONV), pruritus, urinary retention, constipation, and respiratory depression).;Complications associated with nerve blockade, including paresthesia, vascular injury, local anesthetic systemic toxicity (LAST), pneumothorax, dyspnea, hoarseness, Horner's syndrome, total spinal or high epidural block, nerve injury within a two-week period, and spinal cord injury.;Length of Hospital Stay;QoR-15 score at 48 hours postoperatively; Patient satisfaction with postoperative analgesia;

Countries

China

Contacts

Public ContactLi Chenguang

The First People's Hospital of Tianshui

lichguang227@163.com+86 187 9418 9553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026